Eli Lilly and Company Profile Avatar - Palmy Investing

Eli Lilly and Company

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, H…

Drug Manufacturers - General
US, Indianapolis [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Eli Lilly and Company mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of LLY's Analysis
CIK: 59478 CUSIP: 532457108 ISIN: US5324571083 LEI: - UEI: -
Secondary Listings